| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF93 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZNF722 ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 DMRT2 NFATC3 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF724 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 ZNF99 ZNF730 | 1.12e-11 | 1244 | 108 | 29 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF93 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZNF722 ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 DMRT2 NFATC3 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF724 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 ZNF99 ZNF730 | 1.89e-11 | 1271 | 108 | 29 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZNF722 ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 DMRT2 NFATC3 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF724 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 ZNF99 ZNF730 | 1.01e-10 | 1459 | 108 | 30 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZSCAN5A ZNF722 ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 DMRT2 NFATC3 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF724 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 ZNF99 ZNF730 | 2.32e-10 | 1412 | 108 | 29 | GO:0000981 |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 3.27e-05 | 12 | 108 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 5.36e-05 | 14 | 108 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 6.07e-05 | 320 | 108 | 9 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 7.00e-05 | 326 | 108 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF18A SMCHD1 RNF213 CHD8 ATP9B AK9 ATP8B1 ATP8A1 SMC3 DNAH5 | 1.40e-04 | 441 | 108 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 2.87e-04 | 5 | 108 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.54e-04 | 118 | 108 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 4.57e-04 | 28 | 108 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF18A MYO5A SMCHD1 RNF213 CHD8 ATP9B AK9 ATP8B1 ATP8A1 SMC3 DNAH5 | 4.93e-04 | 614 | 108 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 5.98e-04 | 7 | 108 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF493 FEZF2 ZNF594 ZNF600 DMRT2 NFATC3 ZNF43 PLAG1 ZNF85 ZNF99 | 9.18e-04 | 560 | 108 | 10 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF493 FEZF2 ZNF594 ZNF600 DMRT2 NFATC3 ZNF43 PLAG1 ZNF85 ZNF99 | 9.95e-04 | 566 | 108 | 10 | GO:0001216 |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.02e-03 | 9 | 108 | 2 | GO:0090556 | |
| GeneOntologyBiologicalProcess | sexual reproduction | ADAD1 KIF18A GGNBP2 TRPC7 KMT2B MNS1 CATSPERD SMCHD1 TRPC3 TRPC6 APOB PNLDC1 ATAT1 LEPR MEIOC INSL6 SMC3 CFAP97D1 PIK3CA MROH2B SHISA6 | 4.43e-06 | 1312 | 109 | 21 | GO:0019953 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | ADAD1 ZNF93 KIF18A GGNBP2 KMT2B MNS1 CATSPERD SMCHD1 APOB PNLDC1 ATAT1 BMP5 DMRT2 MEIOC INSL6 CFAP97D1 PIK3CA MROH2B PLAG1 SHISA6 | 6.53e-06 | 1235 | 109 | 20 | GO:0003006 |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 6.57e-06 | 186 | 109 | 8 | GO:0030317 | |
| GeneOntologyBiologicalProcess | sperm motility | 8.62e-06 | 193 | 109 | 8 | GO:0097722 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.59e-05 | 210 | 109 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.89e-05 | 215 | 109 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.89e-05 | 215 | 109 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF18A SLK PDCD6IP MNS1 MYO5A CATSPERD APOB STIL ATAT1 TTLL8 MET INSL6 SMC3 CFAP97D1 CEP135 DNAH5 KLC1 | 3.90e-05 | 1058 | 109 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | gamete generation | ADAD1 KIF18A GGNBP2 KMT2B MNS1 CATSPERD SMCHD1 APOB PNLDC1 ATAT1 MEIOC INSL6 CFAP97D1 PIK3CA MROH2B SHISA6 | 5.73e-05 | 982 | 109 | 16 | GO:0007276 |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIF18A MNS1 MYO5A CATSPERD APOB TTLL8 MET INSL6 CFAP97D1 DNAH5 KLC1 | 6.06e-05 | 493 | 109 | 11 | GO:0007018 |
| GeneOntologyBiologicalProcess | cilium movement | 7.46e-05 | 261 | 109 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 1.01e-04 | 46 | 109 | 4 | GO:0010526 | |
| GeneOntologyBiologicalProcess | retrotransposition | 1.20e-04 | 48 | 109 | 4 | GO:0032197 | |
| GeneOntologyBiologicalProcess | transposition | 1.41e-04 | 50 | 109 | 4 | GO:0032196 | |
| GeneOntologyBiologicalProcess | regulation of locomotor rhythm | 1.65e-04 | 4 | 109 | 2 | GO:1904059 | |
| GeneOntologyBiologicalProcess | male gamete generation | ADAD1 KIF18A GGNBP2 MNS1 CATSPERD APOB PNLDC1 ATAT1 MEIOC INSL6 CFAP97D1 MROH2B SHISA6 | 1.92e-04 | 762 | 109 | 13 | GO:0048232 |
| MousePheno | increased chromosomal stability | 4.59e-06 | 6 | 87 | 3 | MP:0010095 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 ZNF99 ZNF730 | 1.63e-14 | 694 | 108 | 26 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 EEA1 ZNF99 ZNF730 | 2.69e-14 | 775 | 108 | 27 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 EEA1 ZNF99 ZNF730 | 2.86e-14 | 777 | 108 | 27 | PS00028 |
| Domain | Znf_C2H2-like | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 EEA1 ZNF99 ZNF730 | 5.11e-14 | 796 | 108 | 27 | IPR015880 |
| Domain | Znf_C2H2 | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 EEA1 ZNF99 ZNF730 | 6.70e-14 | 805 | 108 | 27 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 EEA1 ZNF99 ZNF730 | 7.32e-14 | 808 | 108 | 27 | SM00355 |
| Domain | zf-C2H2 | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF737 ZNF506 ZFHX3 ZNF85 ZNF99 ZNF730 | 1.33e-13 | 693 | 108 | 25 | PF00096 |
| Domain | zf-C2H2_6 | ZNF93 ZNF486 ZNF680 ZNF493 FEZF2 ZNF366 ZBTB41 ZIM3 ZNF600 ZNF43 ZNF92 ZNF735 SNAI2 ZNF737 ZNF506 ZNF85 ZNF99 ZNF730 | 2.52e-13 | 314 | 108 | 18 | PF13912 |
| Domain | - | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZNF735 SNAI2 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 ZNF99 ZNF730 | 6.92e-13 | 679 | 108 | 24 | 3.30.160.60 |
| Domain | KRAB | ZNF93 ZNF486 ZNF680 ZIM3 ZNF708 ZNF43 ZNF92 ZNF735 ZNF737 ZNF506 ZNF85 ZNF99 ZNF738 ZNF730 | 1.92e-08 | 358 | 108 | 14 | PS50805 |
| Domain | KRAB | ZNF93 ZNF486 ZNF680 ZIM3 ZNF708 ZNF43 ZNF92 ZNF735 ZNF737 ZNF506 ZNF85 ZNF99 ZNF738 ZNF730 | 1.92e-08 | 358 | 108 | 14 | PF01352 |
| Domain | KRAB | ZNF93 ZNF486 ZNF680 ZIM3 ZNF708 ZNF43 ZNF92 ZNF735 ZNF737 ZNF506 ZNF85 ZNF99 ZNF738 ZNF730 | 2.81e-08 | 369 | 108 | 14 | SM00349 |
| Domain | KRAB | ZNF93 ZNF486 ZNF680 ZIM3 ZNF708 ZNF43 ZNF92 ZNF735 ZNF737 ZNF506 ZNF85 ZNF99 ZNF738 ZNF730 | 2.91e-08 | 370 | 108 | 14 | IPR001909 |
| Domain | TRP_dom | 3.71e-06 | 6 | 108 | 3 | IPR013555 | |
| Domain | TRP_2 | 3.71e-06 | 6 | 108 | 3 | PF08344 | |
| Domain | TRPC_channel | 6.47e-06 | 7 | 108 | 3 | IPR002153 | |
| Domain | TRP_channel | 3.00e-05 | 11 | 108 | 3 | IPR004729 | |
| Domain | P_typ_ATPase_c | 6.53e-05 | 14 | 108 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 6.53e-05 | 14 | 108 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 6.53e-05 | 14 | 108 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 6.53e-05 | 14 | 108 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 6.53e-05 | 14 | 108 | 3 | PF16209 | |
| Domain | SMC_hinge | 4.89e-04 | 6 | 108 | 2 | PF06470 | |
| Domain | SMC_hinge | 4.89e-04 | 6 | 108 | 2 | SM00968 | |
| Domain | SMC_hinge | 4.89e-04 | 6 | 108 | 2 | IPR010935 | |
| Domain | - | 5.14e-04 | 64 | 108 | 4 | 3.40.50.1000 | |
| Domain | - | 8.25e-04 | 32 | 108 | 3 | 3.40.1110.10 | |
| Domain | - | 8.25e-04 | 32 | 108 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.08e-03 | 35 | 108 | 3 | IPR023299 | |
| Domain | HAD-like_dom | 1.14e-03 | 79 | 108 | 4 | IPR023214 | |
| Domain | P_typ_ATPase | 1.17e-03 | 36 | 108 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 1.17e-03 | 36 | 108 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 1.17e-03 | 36 | 108 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.27e-03 | 37 | 108 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.27e-03 | 37 | 108 | 3 | PF00122 | |
| Domain | Znf_FYVE_PHD | 1.64e-03 | 147 | 108 | 5 | IPR011011 | |
| Domain | DOCK_C | 1.76e-03 | 11 | 108 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.76e-03 | 11 | 108 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.76e-03 | 11 | 108 | 2 | PS51651 | |
| Domain | DHR_1 | 1.76e-03 | 11 | 108 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.76e-03 | 11 | 108 | 2 | PF14429 | |
| Domain | DHR-2 | 1.76e-03 | 11 | 108 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.76e-03 | 11 | 108 | 2 | PF06920 | |
| Domain | DOCK | 1.76e-03 | 11 | 108 | 2 | IPR026791 | |
| Domain | SCAN_BOX | 4.61e-03 | 58 | 108 | 3 | PS50804 | |
| Domain | SCAN | 4.61e-03 | 58 | 108 | 3 | PF02023 | |
| Domain | SCAN_dom | 4.61e-03 | 58 | 108 | 3 | IPR003309 | |
| Domain | Retrov_capsid_C | 4.83e-03 | 59 | 108 | 3 | IPR008916 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF486 ZNF680 KMT2B ZNF493 TRPC3 KAT6A ZIM3 YWHAH MET ZNF708 ZNF600 ZNF43 ZNF92 ZNF735 ZNF724 ZNF737 ZNF506 ZFHX3 ZNF99 ZNF738 ZNF730 | 4.39e-06 | 1387 | 73 | 21 | M734 |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 1.56e-05 | 10 | 73 | 3 | M27330 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.67e-05 | 13 | 73 | 3 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 7.11e-05 | 16 | 73 | 3 | M26945 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.82e-04 | 25 | 73 | 3 | MM14511 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.96e-04 | 176 | 73 | 6 | MM15718 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.56e-04 | 27 | 73 | 3 | MM15053 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 3.56e-04 | 27 | 73 | 3 | M12123 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.65e-04 | 183 | 73 | 6 | M997 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.74e-04 | 66 | 73 | 4 | MM15925 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 3.91e-04 | 6 | 73 | 2 | M27741 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 3.91e-04 | 6 | 73 | 2 | MM15489 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.98e-04 | 28 | 73 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.98e-04 | 28 | 73 | 3 | M27241 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.98e-04 | 28 | 73 | 3 | M924 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 6.41e-04 | 76 | 73 | 4 | MM15051 | |
| Pubmed | 8.02e-12 | 16 | 113 | 6 | 8467795 | ||
| Pubmed | 4.60e-10 | 29 | 113 | 6 | 14563677 | ||
| Pubmed | 7.32e-09 | 8 | 113 | 4 | 2023909 | ||
| Pubmed | ZNF93 ZNF486 ZNF680 ZNF493 ZNF708 ZNF92 ZNF724 ZNF737 ZNF738 | 8.60e-09 | 181 | 113 | 9 | 37372979 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 28526717 | ||
| Pubmed | Zscan5b Deficiency Impairs DNA Damage Response and Causes Chromosomal Aberrations during Mitosis. | 1.33e-07 | 4 | 113 | 3 | 31155506 | |
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 30017393 | ||
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 27732952 | ||
| Pubmed | 1.40e-07 | 15 | 113 | 4 | 15885501 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 21261756 | ||
| Pubmed | Multiple members of a third subfamily of P-type ATPases identified by genomic sequences and ESTs. | 3.32e-07 | 5 | 113 | 3 | 9548971 | |
| Pubmed | TRPC channels are necessary mediators of pathologic cardiac hypertrophy. | 3.32e-07 | 5 | 113 | 3 | 20351294 | |
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 18436303 | ||
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 1.16e-06 | 7 | 113 | 3 | 15757897 | |
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 1.16e-06 | 7 | 113 | 3 | 15336983 | |
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 32350291 | ||
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 38835669 | ||
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 36257322 | ||
| Pubmed | 1.85e-06 | 8 | 113 | 3 | 25471572 | ||
| Pubmed | 1.85e-06 | 8 | 113 | 3 | 15199065 | ||
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 1.85e-06 | 8 | 113 | 3 | 12032305 | |
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 17480026 | ||
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 11290752 | ||
| Pubmed | 3.94e-06 | 10 | 113 | 3 | 27177420 | ||
| Pubmed | 3.94e-06 | 10 | 113 | 3 | 15919184 | ||
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 3.94e-06 | 10 | 113 | 3 | 18588511 | |
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 3.94e-06 | 10 | 113 | 3 | 18989690 | |
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 5.41e-06 | 11 | 113 | 3 | 15469996 | |
| Pubmed | 7.19e-06 | 12 | 113 | 3 | 21914794 | ||
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 9.33e-06 | 13 | 113 | 3 | 11015572 | |
| Pubmed | 9.33e-06 | 13 | 113 | 3 | 19850934 | ||
| Pubmed | 9.33e-06 | 13 | 113 | 3 | 22051675 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22724068 | ||
| Pubmed | Molecular genetic analysis of the dilute-short ear (d-se) region of the mouse. | 1.05e-05 | 2 | 113 | 2 | 3000867 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16587226 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 32140760 | ||
| Pubmed | [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels]. | 1.05e-05 | 2 | 113 | 2 | 20190513 | |
| Pubmed | A Cross-over between the Genes for Short-Ear and Density in the House Mouse. | 1.05e-05 | 2 | 113 | 2 | 16587426 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26832731 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20841608 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26543351 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23529130 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 33333171 | ||
| Pubmed | N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. | 1.05e-05 | 2 | 113 | 2 | 12970363 | |
| Pubmed | PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels. | 1.05e-05 | 2 | 113 | 2 | 24470487 | |
| Pubmed | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. | 1.05e-05 | 2 | 113 | 2 | 9930701 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24453217 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 36512408 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25213992 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 27861908 | ||
| Pubmed | Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. | 1.05e-05 | 2 | 113 | 2 | 29700422 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23800468 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28105583 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10036975 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 36341844 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 35051376 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17748600 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22306362 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19749484 | ||
| Pubmed | Myosin Va controls oligodendrocyte morphogenesis and myelination. | 1.05e-05 | 2 | 113 | 2 | 17942731 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9368034 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25589743 | ||
| Pubmed | Linkage of the Factors for Short-Ear and Density in the House Mouse (MUS MUSCULUS). | 1.05e-05 | 2 | 113 | 2 | 17246548 | |
| Pubmed | A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia. | 1.05e-05 | 2 | 113 | 2 | 35805125 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 2.00e-05 | 49 | 113 | 4 | 9630514 | |
| Pubmed | 2.20e-05 | 17 | 113 | 3 | 22411552 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 24905090 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 28790356 | ||
| Pubmed | Genetic ablation of a mouse gene expressed specifically in brain. | 3.13e-05 | 3 | 113 | 2 | 2303033 | |
| Pubmed | Selective association of TRPC channel subunits in rat brain synaptosomes. | 3.13e-05 | 3 | 113 | 2 | 12377790 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 26553657 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 34764278 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 23541372 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 15972814 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 23938296 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 15358862 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 5556347 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 21757714 | ||
| Pubmed | Orai proteins interact with TRPC channels and confer responsiveness to store depletion. | 3.13e-05 | 3 | 113 | 2 | 17360584 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19812035 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 35396331 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19074769 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 15922295 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 35101055 | ||
| Pubmed | Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. | 3.13e-05 | 3 | 113 | 2 | 23059459 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 32097940 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 27979597 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 36569761 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 10611319 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19052171 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 26033401 | ||
| Pubmed | SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET. | 3.13e-05 | 3 | 113 | 2 | 32111984 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 7493015 | ||
| Pubmed | KIF18A MYO5A VEZT DSP RNF213 YWHAH RFTN1 PTPN14 PPP5C PTPRG CEBPZ CEP135 CPVL | 3.76e-05 | 1049 | 113 | 13 | 27880917 | |
| Pubmed | 3.91e-05 | 58 | 113 | 4 | 31598710 | ||
| Pubmed | 4.26e-05 | 21 | 113 | 3 | 30270038 | ||
| Pubmed | Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. | 5.64e-05 | 23 | 113 | 3 | 26933062 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 28258248 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 1329656 | ||
| Interaction | TRPC7 interactions | 3.04e-06 | 6 | 109 | 3 | int:TRPC7 | |
| Interaction | ANKRD36B interactions | 1.82e-05 | 60 | 109 | 5 | int:ANKRD36B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | ZNF93 ZNF486 ZNF493 ZNF708 ZNF43 ZNF724 ZNF737 ZNF85 ZNF99 ZNF738 ZNF730 | 1.36e-14 | 122 | 113 | 11 | chr19p12 |
| Cytoband | 19p12 | ZNF93 ZNF486 ZNF493 ZNF708 ZNF724 ZNF737 ZNF85 ZNF99 ZNF738 ZNF730 | 2.63e-14 | 90 | 113 | 10 | 19p12 |
| Cytoband | 4q27 | 2.16e-05 | 22 | 113 | 3 | 4q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q27 | 6.84e-05 | 32 | 113 | 3 | chr4q27 | |
| Cytoband | 9p24 | 1.67e-04 | 8 | 113 | 2 | 9p24 | |
| Cytoband | 7q11.21 | 1.16e-03 | 83 | 113 | 3 | 7q11.21 | |
| Cytoband | 19q13.43 | 1.32e-03 | 87 | 113 | 3 | 19q13.43 | |
| Cytoband | 5p15.2 | 2.02e-03 | 27 | 113 | 2 | 5p15.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p24 | 2.27e-03 | 105 | 113 | 3 | chr9p24 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF93 ZNF142 ZNF486 ZNF680 ZNF493 ZSCAN5DP FEZF2 ZNF366 ZSCAN5A ZBTB41 ZIM3 ZNF708 ZNF594 ZNF600 ZNF43 ZNF92 ZSCAN5C ZNF735 SNAI2 ZNF737 ZNF506 PLAG1 ZFHX3 ZNF85 ZNF99 ZNF730 | 4.85e-17 | 718 | 82 | 26 | 28 |
| GeneFamily | ATPase phospholipid transporting | 3.93e-05 | 15 | 82 | 3 | 1210 | |
| GeneFamily | Transient receptor potential cation channels | 2.71e-04 | 28 | 82 | 3 | 249 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KIF18A GGNBP2 SLK ZNF486 MNS1 MYO5A SMCHD1 DOCK10 TAOK3 SMC3 CEBPZ ZNF43 PIK3CA ZNF85 EEA1 | 1.19e-07 | 656 | 111 | 15 | M18979 |
| Coexpression | DURAND_STROMA_NS_UP | 1.79e-06 | 194 | 111 | 8 | MM962 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 SLK SMCHD1 KAT6A ATP8B1 STIL TRIP12 RFTN1 TAOK3 SMC3 NFATC3 CEP135 UTP20 ZFHX3 KLC1 | 3.34e-06 | 856 | 111 | 15 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | CMBL KMT2B AK9 SLC1A1 SHROOM4 MET ZNF708 PTPRG CTNNA3 SHISA6 | 1.15e-05 | 417 | 111 | 10 | M39224 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | MNS1 MYO5A DOCK10 ZBTB41 TRIP12 LEPR ATP8A1 MEIOC PIK3CA SNAI2 | 2.96e-06 | 307 | 105 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | DOCK4 MYO5A ZNF366 SLC26A2 LEPR SHROOM4 PTPRG NFATC3 LRFN5 EEA1 | 4.41e-11 | 184 | 113 | 10 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.18e-08 | 191 | 113 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.68e-07 | 190 | 113 | 7 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 5.88e-07 | 191 | 113 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.53e-07 | 194 | 113 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.67e-07 | 121 | 113 | 6 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.34e-06 | 150 | 113 | 6 | 1aa9320d97ff10994ea024751790524fe133aba9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.28e-06 | 159 | 113 | 6 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.27e-06 | 178 | 113 | 6 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 6.48e-06 | 179 | 113 | 6 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.48e-06 | 179 | 113 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-06 | 184 | 113 | 6 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.31e-06 | 187 | 113 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.31e-06 | 187 | 113 | 6 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 9.10e-06 | 190 | 113 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.38e-06 | 191 | 113 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 9.95e-06 | 193 | 113 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.95e-06 | 193 | 113 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.95e-06 | 193 | 113 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.95e-06 | 193 | 113 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 194 | 113 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.02e-05 | 194 | 113 | 6 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 194 | 113 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 194 | 113 | 6 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 195 | 113 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.06e-05 | 195 | 113 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.15e-05 | 198 | 113 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.15e-05 | 198 | 113 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.15e-05 | 198 | 113 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.18e-05 | 199 | 113 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 113 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 113 | 6 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.73e-05 | 155 | 113 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-05 | 156 | 113 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.18e-05 | 158 | 113 | 5 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | COVID-19-APC-like-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 5.18e-05 | 158 | 113 | 5 | a0d94bd067424783863a48db20976d4c2043600c | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.84e-05 | 162 | 113 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 6.01e-05 | 163 | 113 | 5 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.74e-05 | 167 | 113 | 5 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.74e-05 | 167 | 113 | 5 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 170 | 113 | 5 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 170 | 113 | 5 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-05 | 170 | 113 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.18e-05 | 174 | 113 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 8.63e-05 | 176 | 113 | 5 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.85e-05 | 181 | 113 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 182 | 113 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-04 | 182 | 113 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 182 | 113 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 183 | 113 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.04e-04 | 183 | 113 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 184 | 113 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 184 | 113 | 5 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-04 | 184 | 113 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 184 | 113 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-04 | 185 | 113 | 5 | 3563dd39ec58d3273f95f5bb36b9ccdc0aafb63a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-04 | 185 | 113 | 5 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.09e-04 | 185 | 113 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 185 | 113 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 185 | 113 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 186 | 113 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 186 | 113 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 186 | 113 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.12e-04 | 186 | 113 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 186 | 113 | 5 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 186 | 113 | 5 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-04 | 187 | 113 | 5 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.15e-04 | 187 | 113 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.15e-04 | 187 | 113 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 1.15e-04 | 187 | 113 | 5 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 187 | 113 | 5 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 187 | 113 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.15e-04 | 187 | 113 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.15e-04 | 187 | 113 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.18e-04 | 188 | 113 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.18e-04 | 188 | 113 | 5 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.21e-04 | 189 | 113 | 5 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 113 | 5 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.21e-04 | 189 | 113 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.21e-04 | 189 | 113 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 113 | 5 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-04 | 190 | 113 | 5 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 190 | 113 | 5 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-04 | 190 | 113 | 5 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 190 | 113 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-04 | 190 | 113 | 5 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 113 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.27e-04 | 191 | 113 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 191 | 113 | 5 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-04 | 191 | 113 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-04 | 192 | 113 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 192 | 113 | 5 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.30e-04 | 192 | 113 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 193 | 113 | 5 | 1fdfe08b0c82248545c29b504ac259b093fde29b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 193 | 113 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 193 | 113 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-04 | 193 | 113 | 5 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 193 | 113 | 5 | 5f90e3e526032d82d9dc7e0813fe79ca28dc0719 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.33e-04 | 193 | 113 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 194 | 113 | 5 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| Disease | nicotine dependence (implicated_via_orthology) | 9.68e-06 | 12 | 106 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.03e-05 | 181 | 106 | 6 | DOID:684 (is_implicated_in) | |
| Disease | Neoplasm of the genitourinary tract | 8.63e-05 | 24 | 106 | 3 | cv:C0042065 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 3.53e-04 | 8 | 106 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | HEPATOCELLULAR CARCINOMA | 4.53e-04 | 9 | 106 | 2 | 114550 | |
| Disease | Hepatocellular carcinoma | 4.53e-04 | 9 | 106 | 2 | cv:C2239176 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 9.72e-04 | 13 | 106 | 2 | C0238288 | |
| Disease | triglycerides in medium VLDL measurement | 1.03e-03 | 55 | 106 | 3 | EFO_0022155 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 1.09e-03 | 56 | 106 | 3 | EFO_0022250 | |
| Disease | Malformations of Cortical Development | 1.13e-03 | 14 | 106 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.13e-03 | 14 | 106 | 2 | C0431380 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.13e-03 | 14 | 106 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | phospholipids in VLDL measurement | 1.27e-03 | 59 | 106 | 3 | EFO_0022301 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.27e-03 | 59 | 106 | 3 | EFO_0022289 | |
| Disease | low density lipoprotein triglyceride measurement | 1.30e-03 | 15 | 106 | 2 | EFO_0009946 | |
| Disease | Autosomal recessive primary microcephaly | 1.30e-03 | 15 | 106 | 2 | cv:C3711387 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.30e-03 | 15 | 106 | 2 | EFO_0007804, GO_0036273 | |
| Disease | amenorrhea, response to antineoplastic agent | 1.30e-03 | 15 | 106 | 2 | EFO_0010269, GO_0097327 | |
| Disease | total lipids in VLDL measurement | 1.33e-03 | 60 | 106 | 3 | EFO_0022314 | |
| Disease | language measurement | 1.41e-03 | 134 | 106 | 4 | EFO_0007797 | |
| Disease | gout, hyperuricemia | 1.48e-03 | 16 | 106 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | cholesterol in very large VLDL measurement | 1.67e-03 | 65 | 106 | 3 | EFO_0022230 | |
| Disease | Benign neoplasm of stomach | 1.68e-03 | 17 | 106 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.68e-03 | 17 | 106 | 2 | C0496905 | |
| Disease | Lipidemias | 1.68e-03 | 17 | 106 | 2 | C1706412 | |
| Disease | Carcinoma in situ of stomach | 1.68e-03 | 17 | 106 | 2 | C0154060 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.68e-03 | 17 | 106 | 2 | EFO_0022232 | |
| Disease | Hyperlipidemia | 1.68e-03 | 17 | 106 | 2 | C0020473 | |
| Disease | total lipids in small VLDL | 1.83e-03 | 67 | 106 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 1.83e-03 | 67 | 106 | 3 | EFO_0022175 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.88e-03 | 18 | 106 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.99e-03 | 69 | 106 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | sleep duration | 1.99e-03 | 362 | 106 | 6 | EFO_0005271 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 2.10e-03 | 19 | 106 | 2 | EFO_0003100, GO_1902519 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.10e-03 | 19 | 106 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | psychotic symptoms | 2.43e-03 | 74 | 106 | 3 | EFO_0005940 | |
| Disease | Stomach Carcinoma | 2.57e-03 | 21 | 106 | 2 | C0699791 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.82e-03 | 22 | 106 | 2 | C3711387 | |
| Disease | Primary microcephaly | 2.82e-03 | 22 | 106 | 2 | C0431350 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 2.82e-03 | 22 | 106 | 2 | EFO_0009312 | |
| Disease | Kidney Failure | 2.82e-03 | 22 | 106 | 2 | C0035078 | |
| Disease | tobacco smoke exposure measurement | 3.35e-03 | 24 | 106 | 2 | EFO_0009115 | |
| Disease | Dyslipidemias | 3.35e-03 | 24 | 106 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 3.35e-03 | 24 | 106 | 2 | C0598784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKQFKLVTQCNAKYV | 1151 | P23470 | |
| KVLKCHQENSKNSYT | 101 | P56851 | |
| LYCMNSKKLHNVFNL | 251 | Q86WK6 | |
| FQDESYKKHLKHQCN | 1561 | Q9HCK8 | |
| NTKYKLDIFLKQQQH | 451 | Q86XM0 | |
| KFLIKNCNDFQYESK | 106 | Q04917 | |
| QEAKCKLKSYLQQHG | 546 | Q96M93 | |
| KNVFKKNHVNLYRSE | 1111 | Q9Y2Q0 | |
| NTKFLCIKESKYANN | 81 | O43520 | |
| TLFNKPKSHQKCRQY | 281 | Q14699 | |
| RYKVCNNNGQHKVTK | 551 | Q96NI6 | |
| FQCADHNLKTKKIYF | 421 | Q9Y5S8 | |
| KKQNEYVEKCIHLNR | 556 | Q6TGC4 | |
| RQHLKEKFNKYCRLN | 666 | Q9H3C7 | |
| ELKSFYQQQCHKQIE | 451 | Q8NI77 | |
| ICNNKADYVHKTKTF | 81 | A6NEK1 | |
| CEEKHPRNSIKNQKY | 126 | O43861 | |
| EKQKKYFQKQCHECI | 261 | Q9H3G5 | |
| AEYHQSILAKQQKKF | 256 | Q8WUM4 | |
| KVQVKLSKECFHPYN | 51 | Q8TBE9 | |
| EKVLCKYFHSQNLQK | 511 | Q8TB73 | |
| SNVSFHCIYKKENKI | 346 | P48357 | |
| YCIFQDDKKVFCQKH | 1671 | Q9UMN6 | |
| CKVNQTLKQVIEKFY | 1286 | Q8IVE3 | |
| NNDKQKYTLKINHDC | 201 | P42336 | |
| ECLYHQNDKQISIKK | 701 | Q92794 | |
| DLKFLNNQYAHKLKL | 116 | Q66GS9 | |
| QIKFYSHQLKICSQV | 771 | Q9UI47 | |
| NVKQCEINYVKKFQS | 201 | Q14331 | |
| TKYQHLKAEFKQLQQ | 386 | Q15075 | |
| CKEQHLFLPFSYKNK | 261 | P04114 | |
| HLKYDSQKCFNKARN | 681 | Q96BY6 | |
| YVHLKNACVKNKGQF | 61 | Q8N1I0 | |
| KKHRECLVKDNQKYT | 501 | Q9Y5R5 | |
| NLQKYQAECSQFKAK | 1061 | P15924 | |
| YENKQLCQKIANAHR | 76 | B2RV13 | |
| TSEQKQACKKHELYV | 346 | P22003 | |
| QKLLKFLNKHYNLET | 161 | Q5SQI0 | |
| QACFQQYKTKREEVK | 156 | P43005 | |
| VKFKSYCLKHSQNRQ | 356 | Q92613 | |
| KLYQHEINLFKSKTN | 211 | Q03701 | |
| FECIHPEKQQKKKSY | 241 | Q99829 | |
| EYQLCFHKTKQKLKQ | 441 | Q8TE73 | |
| EKQYKCTICNKAFHQ | 386 | Q8TBJ5 | |
| NLASCYLKQGKFKQA | 386 | Q07866 | |
| KIVNKNNVRCLQHFY | 376 | P08581 | |
| NYCKKLHVQALKNVN | 21 | Q8NEH6 | |
| YNKFKCRILNEKVNT | 311 | A2RTX5 | |
| NRIYICENKEKLQKF | 1756 | Q5TCS8 | |
| YVHPNKAKLNKCSNF | 331 | A2RUB1 | |
| KFYKEVIDKCQSFNQ | 66 | O75691 | |
| QCNTELKKYSHVNKK | 971 | Q9UQE7 | |
| CHEKYDKQIKFTLFK | 566 | A6NHR9 | |
| CKQTLDALNYLHDNK | 136 | Q9H2G2 | |
| NKTVYCEFLKKHDQK | 1436 | B5MCY1 | |
| TQVACFLAKQQNKYK | 281 | Q3BBV2 | |
| TQVACFLAKQQNKYK | 316 | Q86T75 | |
| NINVYIHENAKFQKK | 136 | Q9Y581 | |
| YQECNKIVKQKAFER | 136 | P53041 | |
| QKKLHRKCAYQILVQ | 201 | P53041 | |
| QQVYHKFQNLCKFDV | 436 | Q8NA58 | |
| ATRHKFYKQNKICTE | 296 | Q15678 | |
| CFAYIVDQCKEHKQK | 151 | Q7Z3Q1 | |
| HLQTHSDVKKYQCKN | 231 | O43623 | |
| ANLKAVCKSNEFEKY | 1351 | Q9ULL8 | |
| KKRHEKLDQRQCTNY | 131 | Q6ZSJ9 | |
| TCKVQTKQYKALKNH | 726 | Q9H2K8 | |
| FYRQFCVKLAKKNQE | 1486 | Q7Z745 | |
| KVKLKYCGVHFNSQA | 86 | Q9BSU1 | |
| DKFKCVHQQLLEYKQ | 201 | A7E2S9 | |
| AAKEVNKKQVCYKHN | 611 | Q8IZF2 | |
| NKKQVCYKHNFNASS | 616 | Q8IZF2 | |
| YQDCTFFNKKDILKL | 16 | O75838 | |
| SAILKYLKQQCHAQK | 111 | Q96DG6 | |
| KCLFNHFLKIDNQKF | 301 | Q8N999 | |
| NHCVKTFQEKTQRYK | 36 | Q8WW14 | |
| QQDCTKAFVSKYKLQ | 66 | Q6DJT9 | |
| YKHQQKKGEYVNRCL | 466 | Q63HN8 | |
| LSKICKNFDINHYTK | 241 | Q96JG6 | |
| DTKFQKLQYKDLCTH | 301 | Q96JG6 | |
| YRHAKQNKKNSSCFL | 66 | Q15468 | |
| QSKVFQCDKYGKVFH | 141 | P35789 | |
| QGKIFQCNKYVKVFH | 141 | A8MXY4 | |
| CINHEKIHNAKKSYQ | 266 | Q96PE6 | |
| FQCDKYVKVFHKFLN | 176 | Q8NE65 | |
| IHLCNNAVQKYLKND | 446 | A6PVC2 | |
| QCDKYVKVFHKFPNV | 146 | Q03936 | |
| NQHQIIHTKEKSYKC | 201 | P0CB33 | |
| QSKIFQCDKYVKDFH | 141 | A8MTY0 | |
| QCDKYVKDFHKFSNS | 146 | A8MTY0 | |
| CNQVFTYRKNLNEHK | 441 | P0CG00 | |
| FCVIKKDHQSRNLKY | 71 | Q9BS91 | |
| NKECFKSALYKQTVN | 591 | P50443 | |
| QKYKATFHQCDVCKK | 661 | Q5SVQ8 | |
| VCQKQFTQKSYLKCH | 416 | Q9BUG6 | |
| VQVHFYLCNGKRKKS | 676 | Q12968 | |
| QCDKYVKVFHKFSNS | 146 | Q6ZMV8 | |
| FQKATLRRYKNCEHK | 96 | P17038 | |
| QSKIVQCDKYVKVFH | 136 | P17019 | |
| LCYKSFVQKQTLKAH | 481 | Q8N895 | |
| FQCDKYVKVFHKLLN | 26 | Q6ZR52 | |
| EHQKIHNINKTYECK | 116 | Q96JF6 | |
| FQCDKYVKVAHKFSN | 146 | Q03923 | |
| LKHCKTVLKQEKNNY | 26 | Q6PGP7 | |
| CNYKAKQKFQVVKHV | 1626 | P52746 | |
| KYEVKKFVAHPNCQQ | 371 | Q9Y210 | |
| IFFSQCNKKDDLLHK | 71 | Q9HBM0 | |
| QALKFFNTHQLKCQL | 1256 | Q14669 | |
| KCDVCGKLFNHKQYL | 191 | Q6ZNG1 | |
| SKIFQCGKYVKVFHQ | 151 | Q96H40 | |
| KYLIAACQHLQKKNY | 2236 | Q68DK2 | |
| CDKYVKVFHKFSNSN | 156 | Q8NEM1 | |
| ICQKQFTQKSYLKCH | 416 | A6NGD5 | |
| KAYKQSCNLTTHKII | 236 | Q5JVG8 | |
| IKYEVKKFVAHPNCQ | 301 | Q13507 | |
| KYEVKKFVAHPNCQQ | 316 | Q9HCX4 | |
| NQHQIIHTKEKSYKC | 201 | A0A1W2PQL4 | |
| YNTQLKANFQLHCKT | 991 | Q15911 | |
| QSKIFQCDKYVKVIH | 141 | O75373 | |
| QCDKYVKVIHKFSNS | 146 | O75373 | |
| KLYNTHLNKCALFEK | 526 | Q9Y4I1 |